Partnership aims to develop companion Dx for cancer drugs

09/20/2013 | GenomeWeb Daily News (free registration)

Ventana Medical Systems has entered into a development deal with German drugmaker Boehringer Ingelheim for undisclosed terms. The deal calls for Ventana to use its immunohistochemistry technology platform to create a companion diagnostic to Boehringer's cancer drugs that are under development.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ